Surmount-4

In Follow Up, Obesity
This is a study of tirzepatide in participants with obesity or overweight. The main purpose is to learn more about how tirzepatide maintains…

Surmount-MMO

Enrolling, Obesity
This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide…

Alpaca

In Follow Up, Lipoprotein (a)
The main purpose of this study is to determine the efficacy and safety of LY3819469 in adults with elevated lipoprotein(a). The study will…

Oceanic-AF

Enrolling, Atrial Fibrillation
Researchers are looking for a better way to treat people with atrial fibrillation and prevent stroke or systemic embolism (blood clots…

Influenza Vaccine

In Follow Up
This is a Phase 3, randomized, observer-blinded study to evaluate the efficacy, safety, tolerability, and immunogenicity of a single dose of…

Azalea A Fib

In Follow Up
The purpose of the ANT-006 study is to evaluate the bleeding profile of abelacimab relative to rivaroxaban in patients with atrial…

Bavarian RSV

In Follow Up
Phase 3 randomized, double- blind study comparing recombinant MVA-BN-RSV vaccine vs placebo for efficacy and safety in adults >=60 years of…

Embrace UTI

Enrolling
The purpose of this study is to demonstrate the efficacy of 9-valent extraintestinal pathogenic Escherichia coli vaccine (ExPEC9V) compared…

Renoir

In Follow Up
This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of RSVpreF…

Summit

Heart Failure, Enrolling
The main purpose of this study is to assess the efficacy and safety of Tirzepatide (LY3298176) in participants with heart failure with…

Arrowhead

In Follow Up, High Triglyceride
The purpose of AROANG3-2001 is to evaluate the efficacy and safety of ARO-ANG3 in participants with mixed dyslipidemia. Participants will…

V-Initiate

Cholesterol, In Follow Up
The purpose of this study is to assess the effectiveness of an "inclisiran first" implementation strategy (addition of inclisiran to…
Capital Area Research LLC © Copyright 2023 All rights reserved.
875 Popular Church Rd. Suite 330 Camp Hill, PA - 717.963.8389